JP2008509936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509936A5 JP2008509936A5 JP2007526120A JP2007526120A JP2008509936A5 JP 2008509936 A5 JP2008509936 A5 JP 2008509936A5 JP 2007526120 A JP2007526120 A JP 2007526120A JP 2007526120 A JP2007526120 A JP 2007526120A JP 2008509936 A5 JP2008509936 A5 JP 2008509936A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- dose level
- antigen
- spp
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 29
- 229960005486 vaccine Drugs 0.000 claims 21
- 230000000899 immune system response Effects 0.000 claims 8
- 230000004913 activation Effects 0.000 claims 6
- 229940031551 inactivated vaccine Drugs 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 230000007423 decrease Effects 0.000 claims 5
- 230000028993 immune response Effects 0.000 claims 5
- 244000005700 microbiome Species 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 4
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 230000006698 induction Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- 210000004698 lymphocyte Anatomy 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 241000606161 Chlamydia Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000589989 Helicobacter Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241000204031 Mycoplasma Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000235070 Saccharomyces Species 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 230000024932 T cell mediated immunity Effects 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004904671A AU2004904671A0 (en) | 2004-08-17 | Method for determining dosage for an oral killed vaccine | |
| PCT/AU2005/001229 WO2006017894A1 (en) | 2004-08-17 | 2005-08-17 | Method for determining dosage for an oral killed vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008509936A JP2008509936A (ja) | 2008-04-03 |
| JP2008509936A5 true JP2008509936A5 (https=) | 2008-07-10 |
Family
ID=35907168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526120A Pending JP2008509936A (ja) | 2004-08-17 | 2005-08-17 | 経口不活化ワクチンのための用量を決定するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070269376A1 (https=) |
| EP (1) | EP1793848A4 (https=) |
| JP (1) | JP2008509936A (https=) |
| CN (1) | CN101060858A (https=) |
| CA (1) | CA2578189A1 (https=) |
| WO (1) | WO2006017894A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008109958A1 (en) * | 2007-03-15 | 2008-09-18 | Hunter Immunology Limited | Methods for evaluation of oral vaccines |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778750A (en) * | 1986-02-19 | 1988-10-18 | Imreg, Inc. | Diagnostic methods for immune function |
| AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
| US7914799B2 (en) * | 2001-08-27 | 2011-03-29 | Immunitor USA, Inc. | Anti-fungal composition |
| US8758759B2 (en) * | 2002-10-17 | 2014-06-24 | Enzo Biochem, Inc. | Transmucosal administration of aggregated antigens |
-
2005
- 2005-08-17 US US11/573,890 patent/US20070269376A1/en not_active Abandoned
- 2005-08-17 JP JP2007526120A patent/JP2008509936A/ja active Pending
- 2005-08-17 CN CNA2005800345580A patent/CN101060858A/zh active Pending
- 2005-08-17 EP EP05771767A patent/EP1793848A4/en not_active Withdrawn
- 2005-08-17 CA CA002578189A patent/CA2578189A1/en not_active Abandoned
- 2005-08-17 WO PCT/AU2005/001229 patent/WO2006017894A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Freidag et al. | CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis | |
| Goodnow | Biology of Bordetella bronchiseptica | |
| Harro et al. | Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration | |
| Friedman et al. | Legionella pneumophila pathogenesis and immunity | |
| JP2012153706A (ja) | 粘膜感染症の処置のための組成物および方法 | |
| Kenney et al. | Induction of protective immunity against lethal anthrax challenge with a patch | |
| Zhan et al. | Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro | |
| Asokanathan et al. | A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis | |
| Li et al. | A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines | |
| Olafsdottir et al. | IC31®, a Two‐Component Novel Adjuvant Mixed with a Conjugate Vaccine Enhances Protective Immunity against Pneumococcal Disease in Neonatal Mice | |
| Capozzo et al. | Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers | |
| Geurtsen et al. | Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice | |
| JP2003533489A5 (https=) | ||
| González-González et al. | The protoxin Cry1Ac of Bacillus thuringiensis improves the protection conferred by intranasal immunization with Brucella abortus RB51 in a mouse model | |
| Jiang et al. | Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective | |
| JP2019513722A (ja) | 変異ボルデテラ菌株および使用方法 | |
| Barluzzi et al. | Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain | |
| JP2008509936A5 (https=) | ||
| Homayoon et al. | Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice | |
| Card et al. | Modulation of allergic airway inflammation by the oral pathogen Porphyromonas gingivalis | |
| Biet et al. | Recombinant Mycobacterium bovis BCG producing IL‐18 reduces IL‐5 production and bronchoalveolar eosinophilia induced by an allergic reaction | |
| CN108220183A (zh) | 一株马流产沙门氏菌菌株smxj-97及其在马流产沙门氏菌疫苗中的应用 | |
| Sosroseno et al. | l‐arginine‐dependent nitric oxide production of a murine macrophage‐like RAW 264.7 cell line stimulated with Porphyromonas gingivalis lipopolysaccharide | |
| WO2009008912A3 (en) | Mycobacterial mutants inducing il-12 | |
| Jordan et al. | Modulation of the humoral immune response of swine and mice mediated by toxigenic Pasteurella multocida |